FDA panel advises against omeprazole as over the counter drug

被引：0

|

作者：

Gottlieb, S

机构：

来源：

BRITISH MEDICAL JOURNAL | 2000年 / 321卷 / 7269期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1099 / 1099

页数：1

相关论文

共 50 条

[1] FDA panel advises against cold drug, citing concerns over drug interactions
Cimons, M
ASM NEWS, 2002, 68 (06): : 263 - 264
[2] FDA panel advises easing restrictions on rosiglitazone
Tucker, Miriam E.
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[3] Panel advises against rimonabant approval
Traynor, Kate
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (14) : 1460 - 1461
[4] FDA advises against vapotherm respiratory device
Porterfield, AM
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (02) : 308 - 308
[5] FDA advises drug sponsors on supplemental drug applications
不详
JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2003, 222 (01): : 10 - 10
[6] FDA advises against needleless flu vaccinations
Riedmann, Eva M.
HUMAN VACCINES, 2011, 7 (12): : 1247 - 1247
[7] US FDA panel advises banning of two asthma drugs
Reactions Weekly, 2009, 1238 (1) : 2 - 2
[8] FDA advises against using Venom Hyperdrive 3.0
Reactions Weekly, 2009, 1238 (1) : 2 - 2
[9] FDA advises drug interaction studies for Merck's `Emend'
Reactions Weekly, 2003, 943 (1) : 3 - 3
[10] FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone
Cohen, Barbara R.
Mahoney, Karen M.
Baro, Elande
Squire, Claudia
Beck, Melissa
Travis, Sara
Pike-McCrudden, Amanda
Izem, Rima
Woodcock, Janet
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22): : 2129 - 2136

← 1 2 3 4 5 →